Jaguar Health vs Scilex Holding
Scilex Holding is the larger business, with $30.3m of revenue in fiscal 2025 against $11.5m for Jaguar Health (2.6 times as much). Jaguar Health grew faster (-1.5% against -46.5%). Jaguar Health kept more of each dollar of sales as profit: a net margin of -465.4% against -1236.4%.
| Latest fiscal year | Jaguar HealthJAGX, 2025 | Scilex HoldingSCLX, 2025 |
|---|---|---|
| Revenue | $11.5m | $30.3m |
| Revenue growth | -1.5% | -46.5% |
| Net income | −$53.6m | −$374m |
| Operating margin | -398.8% | -1143.7% |
| Net margin | -465.4% | -1236.4% |
| Return on equity | — | — |
| Free cash flow | −$23.7m | $3.7m |
| Cash | $968,000 | $5.0m |
| Total debt | $42.5m | $106m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 34 |
| Market value | $439,515 | $13.4m |
| Price vs our value range | — | — |
| Moat score | 32 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 13 sales |